HDYO is invested in breaking down the many barriers of Huntington's disease. We hosted a Casual Conversation with Wave Life Sciences to talk about their allele-selective approach to Huntington lowering and how they interact with the advocacy communities.

The Breaking Down Barriers is sponsored by Teva Pharmaceutical, uniQure, Neurocrine Biosciences, Roche and Sage Therapeutics.

**This conversation can be translated through subtitles in many languages and can be accessed after the premiere as well.